ArticleCell reports. Medicine2023

Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases.

Jiawei Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.